T4121 Human CD8 + Cytotoxic Killer T Cells

T4121 Human CD8+ Cytotoxic Killer T Cells express CD8+, expanded with anti-CD3/CD28 + 100 IU/mL IL-2 for 9–12 days, for CTL biology, tumor cell killing, viral immunopathology, immune checkpoint (PD-1/CTLA-4), and CAR-T research. 300×g at thawing. Supplied by ABM as 5×10⁵ cells/1.0 ml, frozen; BSL-2; RUO. MTA required.